Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.0950 (0.5%) ($10.0950 - $10.0950) on Tue. Apr. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.93% (three month average) | RSI | 25 | Latest Price | $10.0950(0.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -11.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -3.465% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) IGOV(-7%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.465% (StdDev 6.93%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-11.5(-213.92%) | Inflection Point | Yes | Resistance Level | $11.48 | 5 Day Moving Average | $10.06(0.35%) | 10 Day Moving Average | $10.22(-1.22%) | 20 Day Moving Average | $11.48(-12.06%) | To recent high | -25.9% | To recent low | 34.7% | Market Cap | $1.781b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |